How to buy Phibro Animal Health Corporation stock | $19.42

Phibro Animal Health Corporation is a drug manufacturers-specialty & generic business based in the US. Phibro Animal Health Corporation shares (PAHC) are listed on the NASDAQ and all prices are listed in US Dollars. Phibro Animal Health Corporation employs 1,700 staff and has a trailing 12-month revenue of around USD$805.8 million.

How to buy shares in Phibro Animal Health Corporation

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Phibro Animal Health Corporation. Find the stock by name or ticker symbol: PAHC. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Phibro Animal Health Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$19.42, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Phibro Animal Health Corporation, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Phibro Animal Health Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Phibro Animal Health Corporation share price

Use our graph to track the performance of PAHC stocks over time.

Phibro Animal Health Corporation shares at a glance

• Key figures

Information last updated 2020-12-29.

Latest market close	USD$19.42
52-week range	USD$16.1655 - USD$28.7542
50-day moving average	USD$18.8503
200-day moving average	USD$20.4285
Wall St. target price	USD$20
PE ratio	17.7757
Dividend yield	USD$0.48 (2.5%)
Earnings per share (TTM)	USD$1.07

Buy Phibro Animal Health Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Phibro Animal Health Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Phibro Animal Health Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Phibro Animal Health Corporation price performance over time

Historical closes compared with the close of $19.42 from 2020-12-31

1 week (2021-01-07)	-6.63%
1 month (2020-12-15)	1.52%
3 months (2020-10-15)	6.35%
6 months (2020-07-15)	-26.33%

1 year (2020-01-15)	-24.47%
2 years (2019-01-15)	-38.89%
3 years (2018-01-13)	N/A
5 years (2016-01-15)	28.77

Is Phibro Animal Health Corporation under- or over-valued?

Valuing Phibro Animal Health Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Phibro Animal Health Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Phibro Animal Health Corporation's P/E ratio

Phibro Animal Health Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, Phibro Animal Health Corporation shares trade at around 18x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Phibro Animal Health Corporation's PEG ratio

Phibro Animal Health Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6615. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Phibro Animal Health Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Phibro Animal Health Corporation's EBITDA

Phibro Animal Health Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$103.5 million.

The EBITDA is a measure of a Phibro Animal Health Corporation's overall financial performance and is widely used to measure a its profitability.

Phibro Animal Health Corporation financials

Revenue TTM	USD$805.8 million
Operating margin TTM	8.92%
Gross profit TTM	USD$257.2 million
Return on assets TTM	5.67%
Return on equity TTM	21.72%
Profit margin	5.38%
Book value	$4.756
Market capitalisation	USD$769.4 million

TTM: trailing 12 months

Shorting Phibro Animal Health Corporation shares

There are currently 950,317 Phibro Animal Health Corporation shares held short by investors – that's known as Phibro Animal Health Corporation's "short interest". This figure is 2.4% down from 973,752 last month.

There are a few different ways that this level of interest in shorting Phibro Animal Health Corporation shares can be evaluated.

Phibro Animal Health Corporation's "short interest ratio" (SIR)

Phibro Animal Health Corporation's "short interest ratio" (SIR) is the quantity of Phibro Animal Health Corporation shares currently shorted divided by the average quantity of Phibro Animal Health Corporation shares traded daily (recently around 161344.1426146). Phibro Animal Health Corporation's SIR currently stands at 5.89. In other words for every 100,000 Phibro Animal Health Corporation shares traded daily on the market, roughly 5890 shares are currently held short.

However Phibro Animal Health Corporation's short interest can also be evaluated against the total number of Phibro Animal Health Corporation shares, or, against the total number of tradable Phibro Animal Health Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Phibro Animal Health Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Phibro Animal Health Corporation shares in existence, roughly 20 shares are currently held short) or 0.0653% of the tradable shares (for every 100,000 tradable Phibro Animal Health Corporation shares, roughly 65 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Phibro Animal Health Corporation.

Find out more about how you can short Phibro Animal Health Corporation stock.

Phibro Animal Health Corporation share dividends

Dividend payout ratio: 41.38% of net profits

Recently Phibro Animal Health Corporation has paid out, on average, around 41.38% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.5% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Phibro Animal Health Corporation shareholders could enjoy a 2.5% return on their shares, in the form of dividend payments. In Phibro Animal Health Corporation's case, that would currently equate to about $0.48 per share.

While Phibro Animal Health Corporation's payout ratio might seem fairly standard, it's worth remembering that Phibro Animal Health Corporation may be investing much of the rest of its net profits in future growth.

Phibro Animal Health Corporation's most recent dividend payout was on 16 December 2020. The latest dividend was paid out to all shareholders who bought their shares by 24 November 2020 (the "ex-dividend date").

Phibro Animal Health Corporation share price volatility

Over the last 12 months, Phibro Animal Health Corporation's shares have ranged in value from as little as $16.1655 up to $28.7542. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Phibro Animal Health Corporation's is 0.4698. This would suggest that Phibro Animal Health Corporation's shares are less volatile than average (for this exchange).

Phibro Animal Health Corporation overview

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It also operates in Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.

Frequently asked questions

• What percentage of Phibro Animal Health Corporation is owned by insiders or institutions?

  Currently 0.397% of Phibro Animal Health Corporation shares are held by insiders and 108.417% by institutions.

• How many people work for Phibro Animal Health Corporation?

  Latest data suggests 1,700 work at Phibro Animal Health Corporation.

• When does the fiscal year end for Phibro Animal Health Corporation?

  Phibro Animal Health Corporation's fiscal year ends in June.

• Where is Phibro Animal Health Corporation based?

  Phibro Animal Health Corporation's address is: Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712

• What is Phibro Animal Health Corporation's ISIN number?

  Phibro Animal Health Corporation's international securities identification number is: US71742Q1067

• What is Phibro Animal Health Corporation's CUSIP number?

  Phibro Animal Health Corporation's Committee on Uniform Securities Identification Procedures number is: 71742Q106